Preparation method and application of chlorella exosome and mRNA complex nanoparticles
By using Chlorella exosomes as carriers and combining them with electroporation to prepare mRNA composite nanoparticles, the problems of stability and low cellular uptake efficiency of existing mRNA delivery systems have been solved, realizing safe and scalable mRNA delivery and expanding its application in the biomedical field.
Patent Information
- Application Number
- CN202610079802.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2026-01-21
- Publication Date
- 2026-06-02
- Estimated Expiration
- 2046-01-21
AI Technical Summary
Existing mRNA delivery systems suffer from problems such as poor stability, low cellular uptake efficiency, strong immunogenicity, and delivery difficulties, which limit their widespread application in the biomedical field. In particular, exosomes derived from mammalian cells have limitations such as low yield, complex extraction process, and high cost.
Using Chlorella exosomes as carriers, mRNA composite nanoparticles were prepared under specific culture conditions and by electroporation. Taking advantage of the natural targeting and biocompatibility of Chlorella exosomes, targeted delivery and intracellular expression of mRNA were achieved.
This has enabled the safe and scalable production of mRNA, improved intracellular expression efficiency and stability, reduced immune rejection and toxic side effects, and broadened the application prospects of mRNA in vaccines, tumor immunology and gene therapy.